Financing & Partnership News Send Shares of this Stem-Cell Therapy Company on a Tear

Stock Information for Hemostemix

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Hemostemix

Hemostemix's VesCell Sales are Legal in Florida as it Pivots to Allow Non-FDA Approved Stem Cell Treatments!
Croom Lawrence Joins Hemostemix with Revenue Share Agreement and VesCell.Health Launch
Hemostemix Announces Lead Order of $1,500,000 and the Full Repayment of $2,500,000 Convertible Debenture
Hemostemix Closes Private Placement of $469,366
Hemostemix Presents at TERMIS 2025, Freiburg, Germany
Hemostemix Closes Private Placement of USD $336,500 at $0.295 per Share
Hemostemix at Invest Stuttgart
Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.